Suppr超能文献

一种新型荧光探针揭示了饥饿控制淀粉样前体蛋白向溶酶体的定向。

A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome.

机构信息

Lysosomal Diseases Research Unit, Nutrition and Metabolism Theme, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide 5001, South Australia, Australia.

Lysosomal Diseases Research Unit, Nutrition and Metabolism Theme, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide 5001, South Australia, Australia; EMBL Australia, Australia.

出版信息

Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1554-1565. doi: 10.1016/j.bbamcr.2017.06.011. Epub 2017 Jun 19.

Abstract

Alzheimer's disease is the most important cause of dementia but there is no therapy that has been demonstrated to stop or slow disease progression. Amyloid precursor protein (APP) is the source of amyloid-β (Aβ), which aggregates in Alzheimer's disease to form toxic oligomeric species. The endo-lysosomal system can clear APP and Aβ from the cell if these molecular species are trafficked through to the lysosome. Currently, there are no easy methods available for the analysis of lysosomal APP trafficking. We therefore generated a fusion protein (tandem-fluorescent, or tf-APP) that allows detection of changes in APP trafficking using accessible techniques such as flow cytometry. This permits rapid analysis or screening of genes and compounds that alter APP processing in the cell. Using our novel molecular probe, we determined that starvation induces trafficking of APP and APP-carboxy-terminal fragments (APP-CTFs) to the degradative endo-lysosomal network. In line with this finding, suppression of mTOR signalling using AZD8055 also strongly induced trafficking of APP to the endo-lysosomal system. Remarkably, activation of mTOR signalling via RHEB over-expression inhibited the starvation-induced autophagy but did not affect trafficking of tf-APP. These results show tf-APP can be used to determine how APP is trafficked through the lysosomal system of the cell. This molecular probe is therefore useful for determining the molecular mechanism behind the commitment of APP to the degradative pathway or for screening compounds that can induce this effect. This is important as clearance of APP and APP-CTF provides an important potential therapeutic strategy for Alzheimer's disease.

摘要

阿尔茨海默病是痴呆症最重要的病因,但目前尚无已证实可阻止或减缓疾病进展的疗法。淀粉样前体蛋白(APP)是淀粉样β(Aβ)的来源,Aβ 在阿尔茨海默病中聚集形成毒性寡聚体。如果这些分子物质通过内体-溶酶体途径转运到溶酶体,内体-溶酶体系统可以清除细胞中的 APP 和 Aβ。目前,尚无用于分析溶酶体 APP 转运的简单方法。因此,我们生成了一种融合蛋白(串联荧光蛋白,或 tf-APP),该蛋白允许使用流式细胞术等可及技术检测 APP 转运的变化。这使得可以快速分析或筛选改变细胞中 APP 加工的基因和化合物。使用我们的新型分子探针,我们确定饥饿诱导 APP 和 APP-羧基末端片段(APP-CTFs)向降解性内体-溶酶体网络的转运。与这一发现一致,使用 AZD8055 抑制 mTOR 信号也强烈诱导 APP 向内体-溶酶体系统的转运。值得注意的是,通过 RHEB 过表达激活 mTOR 信号会抑制饥饿诱导的自噬,但不会影响 tf-APP 的转运。这些结果表明 tf-APP 可用于确定 APP 如何通过细胞的溶酶体系统转运。因此,该分子探针可用于确定 APP 向降解途径的定向的分子机制,或用于筛选可诱导这种效应的化合物。这很重要,因为清除 APP 和 APP-CTF 为阿尔茨海默病提供了一种重要的潜在治疗策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验